Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Kylie Jenner sued by 2nd ex-housekeeper alleging workplace discrimination

May 1, 2026

Amazon’s built-in AI price history expands to show the entire last year

May 1, 2026

GuardHouse Camera Analyzed: All You Need To Know About the GuardHouse Watch Eye

May 1, 2026

Shippers ‘losing faith’ in CBSA tech systems amid ongoing outages, glitches

May 1, 2026

Neither Norway nor Singapore: Decoding Canada’s new sovereign wealth fund

May 1, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » GTLB Class Action Alert – Shareholder Rights Law Firm Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the GitLab Inc. Class Action Lawsuit
Press Release

GTLB Class Action Alert – Shareholder Rights Law Firm Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the GitLab Inc. Class Action Lawsuit

By News RoomSeptember 16, 20243 Mins Read
GTLB Class Action Alert – Shareholder Rights Law Firm Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the GitLab Inc. Class Action Lawsuit
Share
Facebook Twitter LinkedIn Pinterest Email

SAN DIEGO, Sept. 16, 2024 (GLOBE NEWSWIRE) —

Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired GitLab Inc. (NASDAQ: GTLB) securities between June 6, 2023 and March 4, 2024. GitLab is a global software company that designs and develops software solutions.

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

The Allegations: Robbins LLP is Investigating Allegations that GitLab Inc. (GTLB) Misled Investors Regarding Demand for its Product

According to the complaint, during the class period, defendants created the false impression that they possessed reliable information pertaining to the Company’s ability to develop and incorporate AI throughout the software development cycle to optimize code generation thereby increasing market demand and making all levels of software development more affordable and properly monetizing its AI features. In truth, there was weak market demand for Gitlab’s touted AI features and the Company was incurring an increasing amount of expenses involving JiHu, its joint venture in China, as well as the annual company-wide summit. Defendants misled investors by continually highlighting its AI-driven innovations to develop software more efficiently and drive market share demands.

Plaintiff alleges that on March 4, 2024, GitLab issued a press release reporting strong Q1 2024 results and then immediately followed this with a disclosure announcing lower than expected full-year guidance for 2025. GitLab attributed it to time needed to “build pipeline and close deals on new products.” On this news, the price of GitLab’s common stock declined from $74.47 per share on March 4, 2024, to $58.84 per share on March 5, 2024, a decline of about 21%.

What Now: You may be eligible to participate in the class action against GitLab Inc. Shareholders who want to serve as lead plaintiff for the class must submit their application to the court by November 4, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.  

About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against GitLab Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0b88c72f-afbc-4f12-932d-44bb72bd4f8d

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

GuardHouse Camera Analyzed: All You Need To Know About the GuardHouse Watch Eye

Bevacizumab Biosimilars Market Trastuzumab Biosimilars Market Analysis Report 2026: $2.42 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

B2BROKER Group Puts AI at the Core of B2TRADER as Technology Enters a New Era

Adalimumab, Infliximab and Etanercept Biosimilars Trastuzumab Biosimilars Research Report 2026: $8.05 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035

Whitespace Makes Iris, AI Intelligence Analysis Agent, Generally Available to Authorized DoW and IC Users

Based Eggman Announces Stage 3 Presale Progress

Systemic Mastocytosis (SM) Treatment Market 2026-2035: Industry to More Than Double in Size, Led by Sanofi, AdvaCare Pharma, and Cogent Biosciences

Investment Banking and Trading Services Market Analysis Report 2026: Bulge-Bracket Banks vs. Elite Boutiques

Shares, Opportunities and Strategies in the $1.7 Billion Ice Cream Maker Market, 2026-2035

Editors Picks

Amazon’s built-in AI price history expands to show the entire last year

May 1, 2026

GuardHouse Camera Analyzed: All You Need To Know About the GuardHouse Watch Eye

May 1, 2026

Shippers ‘losing faith’ in CBSA tech systems amid ongoing outages, glitches

May 1, 2026

Neither Norway nor Singapore: Decoding Canada’s new sovereign wealth fund

May 1, 2026

Latest News

Bevacizumab Biosimilars Market Trastuzumab Biosimilars Market Analysis Report 2026: $2.42 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026

B2BROKER Group Puts AI at the Core of B2TRADER as Technology Enters a New Era

May 1, 2026

Adalimumab, Infliximab and Etanercept Biosimilars Trastuzumab Biosimilars Research Report 2026: $8.05 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035

May 1, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version